1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Septicaemia Global Clinical Trials Review, H2, 2014

Septicaemia Global Clinical Trials Review, H2, 2014

  • December 2014
  • -
  • Global Data
  • -
  • 65 pages

Septicaemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Septicaemia Global Clinical Trials Review, H2, 2014" provides data on the Septicaemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septicaemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Septicaemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Septicaemia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Septicaemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Septicaemia to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Septicaemia to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Septicaemia 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Septicaemia Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Venus Remedies Limited 30
Clinical Trial Overview of Venus Remedies Limited 30
Sanofi 31
Clinical Trial Overview of Sanofi 31
Shire Plc 32
Clinical Trial Overview of Shire Plc 32
Pharmaero ApS 33
Clinical Trial Overview of Pharmaero ApS 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Huons Co., Ltd. 35
Clinical Trial Overview of Huons Co., Ltd. 35
Curacyte AG 36
Clinical Trial Overview of Curacyte AG 36
Clinical Trial Overview of Top Institutes / Government 37
University of Oxford 37
Clinical Trial Overview of University of Oxford 37
Friedrich-Schiller-Universitat Jena 38
Clinical Trial Overview of Friedrich-Schiller-Universitat Jena 38
Helsinki University Central Hospital 39
Clinical Trial Overview of Helsinki University Central Hospital 39
University Hospitals 40
Clinical Trial Overview of University Hospitals 40
European Commission 41
Clinical Trial Overview of European Commission 41
University of Cologne 42
Clinical Trial Overview of University of Cologne 42
Samsung Medical Center 43
Clinical Trial Overview of Samsung Medical Center 43
University Medical Center Freiburg 44
Clinical Trial Overview of University Medical Center Freiburg 44
Assistance Publique - Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 45
University of California, San Francisco 46
Clinical Trial Overview of University of California, San Francisco 46
Five Key Clinical Profiles 47
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65

List of Tables
Septicaemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Septicaemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Septicaemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Septicaemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Septicaemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Septicaemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Septicaemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Septicaemia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Septicaemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Septicaemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Septicaemia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Septicaemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Septicaemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Septicaemia Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Septicaemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Septicaemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Septicaemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Septicaemia Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Septicaemia Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Septicaemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Septicaemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Septicaemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Septicaemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Septicaemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Venus Remedies Limited, 2014* 30
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 31
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 32
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaero ApS, 2014* 33
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Huons Co., Ltd., 2014* 35
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Curacyte AG, 2014* 36
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 37
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Friedrich-Schiller-Universitat Jena, 2014* 38
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014* 39
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals, 2014* 40
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by European Commission, 2014* 41
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014* 42
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 43
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Freiburg, 2014* 44
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 45
Septicaemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 46

List of Figures
Septicaemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Septicaemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Septicaemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Septicaemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Septicaemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Septicaemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Septicaemia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Septicaemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Septicaemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Septicaemia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Septicaemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Septicaemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Septicaemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Septicaemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Septicaemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Septicaemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Septicaemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Septicaemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Septicaemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Septicaemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Septicaemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 64

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.